GAM
TFFP

Gemmer Asset Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Gemmer Asset Management’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-20
Closed -$4K – 1324
2021
Q4 		$4K Buy
+20
New +$3.87K ﹤0.01% 1094

Other funds holding TFFP

DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
PCM
Princeton Capital Management Red Bank, New Jersey $367M AUM 45.24% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Gemmer Asset Management's TFFP Position: Q1 2022 in Review

Gemmer Asset Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q1 2022, closing a stake of 20 shares — an estimated $4K sold.

Gemmer Asset Management first reported a position in TFFP in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 43 funds tracked by Wall St. Rank hold TFFP as of Q1 2022.

  • Gemmer Asset Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Gemmer Asset Management sold 20 TFF Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $4K.
  • Gemmer Asset Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Gemmer Asset Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $4K in Q4 2021.
  • 43 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Gemmer Asset Management's 13F filing for Q1 2022, filed 20 Apr 2022.